» Articles » PMID: 26051096

Embryo Transfer Practices and Perinatal Outcomes by Insurance Mandate Status

Overview
Journal Fertil Steril
Date 2015 Jun 9
PMID 26051096
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To use linked assisted reproductive technology (ART) surveillance and birth certificate data to compare ET practices and perinatal outcomes for a state with a comprehensive mandate requiring coverage of IVF services versus states without a mandate.

Design: Retrospective cohort study.

Setting: Not applicable.

Patient(s): Live-birth deliveries ascertained from linked 2007-2009 National ART Surveillance System and birth certificate data for a state with an insurance mandate (Massachusetts) and two states without a mandate (Florida and Michigan).

Intervention(s): None.

Main Outcome Measure(s): Number of embryos transferred, multiple births, low birth weight, preterm delivery.

Result(s): Of the 230,038 deliveries in the mandate state and 1,026,804 deliveries in the nonmandate states, 6,651 (2.9%) and 8,417 (0.8%), respectively, were conceived by ART. Transfer of three or more embryos was more common in nonmandate states, although the effect was attenuated for women 35 years or older (33.6% vs. 39.7%; adjusted relative risk [RR], 1.46; 95% confidence interval [CI], 1.17-1.81) versus women younger than 35 (7.0% vs. 26.9%; adjusted RR, 4.18; 95% CI, 2.74-6.36). Lack of an insurance mandate was positively associated with triplet/higher order deliveries (1.0% vs. 2.3%; adjusted RR, 2.44; 95% CI, 1.81-3.28), preterm delivery (22.6% vs. 30.7%; adjusted RR, 1.31; 95% CI, 1.20-1.42), and low birth weight (22.3% vs. 29.5%; adjusted RR, 1.28; 95% CI, 1.17-1.40).

Conclusion(s): Compared with nonmandate states, the mandate state had higher overall rates of ART use. Among ART births, lack of an infertility insurance mandate was associated with increased risk for adverse perinatal outcomes.

Citing Articles

Association of state insurance coverage mandates with assisted reproductive technology care discontinuation.

Lee J, DeSantis C, Yartel A, Kissin D, Kawwass J Am J Obstet Gynecol. 2022; 228(3):315.e1-315.e14.

PMID: 36368429 PMC: 11000072. DOI: 10.1016/j.ajog.2022.10.046.


Public attitudes in the United States toward insurance coverage for in vitro fertilization and the provision of infertility services to lower income patients.

Ho J, Aghajanova L, Mok-Lin E, Hoffman J, Smith J, Herndon C F S Rep. 2022; 3(2 Suppl):122-129.

PMID: 35937442 PMC: 9349243. DOI: 10.1016/j.xfre.2021.09.002.


Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment.

Peipert B, Montoya M, Bedrick B, Seifer D, Jain T Reprod Biol Endocrinol. 2022; 20(1):111.

PMID: 35927756 PMC: 9351254. DOI: 10.1186/s12958-022-00984-5.


Assisted Reproductive Technology Surveillance - United States, 2018.

Sunderam S, Kissin D, Zhang Y, Jewett A, Boulet S, Warner L MMWR Surveill Summ. 2022; 71(4):1-19.

PMID: 35176012 PMC: 8865855. DOI: 10.15585/mmwr.ss7104a1.


Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo....

Robins J, Khair A, Widra E, Alper M, Nelson W, Foster E F S Rep. 2021; 1(3):257-263.

PMID: 34223253 PMC: 8244378. DOI: 10.1016/j.xfre.2020.09.010.


References
1.
Henne M, Bundorf M . Insurance mandates and trends in infertility treatments. Fertil Steril. 2007; 89(1):66-73. DOI: 10.1016/j.fertnstert.2007.01.167. View

2.
Banks N, Norian J, Bundorf M, Henne M . Insurance mandates, embryo transfer, outcomes--the link is tenuous. Fertil Steril. 2010; 94(7):2776-9. DOI: 10.1016/j.fertnstert.2010.05.037. View

3.
Martin J, Bromer J, Sakkas D, Patrizio P . Insurance coverage and in vitro fertilization outcomes: a U.S. perspective. Fertil Steril. 2010; 95(3):964-9. DOI: 10.1016/j.fertnstert.2010.06.030. View

4.
Yelland L, Salter A, Ryan P . Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. 2011; 174(8):984-92. DOI: 10.1093/aje/kwr183. View

5.
Bitler M, Schmidt L . Utilization of infertility treatments: the effects of insurance mandates. Demography. 2011; 49(1):125-49. PMC: 5833298. DOI: 10.1007/s13524-011-0078-4. View